Scancell Holdings Future Growth
Future criteria checks 0/6
Scancell Holdings's revenue and earnings are forecast to decline at 25% and 22.4% per annum respectively while EPS is expected to decline by 23.1% per annum.
Key information
-22.4%
Earnings growth rate
-23.1%
EPS growth rate
| Biotechs earnings growth | 42.4% |
| Revenue growth rate | -25.0% |
| Future return on equity | n/a |
| Analyst coverage | Low |
| Last updated | 18 Nov 2024 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 4/30/2027 | N/A | N/A | -15 | N/A | 1 |
| 4/30/2026 | N/A | -10 | -14 | -6 | 3 |
| 4/30/2025 | 2 | -13 | -11 | -8 | 3 |
| 4/30/2024 | N/A | -6 | -16 | -16 | N/A |
| 1/31/2024 | N/A | -8 | -13 | -13 | N/A |
| 10/31/2023 | N/A | -10 | -11 | -11 | N/A |
| 7/31/2023 | 3 | -11 | -9 | -9 | N/A |
| 4/30/2023 | 5 | -12 | -8 | -8 | N/A |
| 1/31/2023 | 5 | -12 | -9 | -9 | N/A |
| 10/31/2022 | 5 | -13 | -11 | -10 | N/A |
| 7/31/2022 | 3 | -9 | -11 | -10 | N/A |
| 4/30/2022 | N/A | -5 | -11 | -10 | N/A |
| 1/31/2022 | N/A | -6 | -11 | -10 | N/A |
| 10/31/2021 | N/A | -8 | -11 | -9 | N/A |
| 7/31/2021 | N/A | -12 | -10 | -8 | N/A |
| 4/30/2021 | N/A | -15 | -9 | -8 | N/A |
| 1/31/2021 | N/A | -11 | -7 | -7 | N/A |
| 10/31/2020 | N/A | -7 | -6 | -5 | N/A |
| 7/31/2020 | N/A | -6 | -5 | -5 | N/A |
| 4/30/2020 | N/A | -6 | -5 | -5 | N/A |
| 1/31/2020 | N/A | -5 | -5 | -5 | N/A |
| 10/31/2019 | N/A | -5 | -6 | -6 | N/A |
| 7/31/2019 | N/A | -5 | -6 | -6 | N/A |
| 4/30/2019 | N/A | -6 | -7 | -7 | N/A |
| 1/31/2019 | N/A | -6 | -6 | -6 | N/A |
| 10/31/2018 | N/A | -5 | -6 | -6 | N/A |
| 7/31/2018 | N/A | -5 | -5 | -5 | N/A |
| 4/30/2018 | N/A | -4 | -4 | -4 | N/A |
| 1/31/2018 | N/A | -4 | N/A | -4 | N/A |
| 10/31/2017 | N/A | -4 | N/A | -4 | N/A |
| 7/31/2017 | N/A | -4 | N/A | -4 | N/A |
| 4/30/2017 | N/A | -4 | N/A | -4 | N/A |
| 1/31/2017 | N/A | -3 | N/A | -3 | N/A |
| 10/31/2016 | N/A | -3 | N/A | -3 | N/A |
| 7/31/2016 | N/A | -3 | N/A | -3 | N/A |
| 4/30/2016 | N/A | -3 | N/A | -2 | N/A |
| 1/31/2016 | N/A | -2 | N/A | -2 | N/A |
| 10/31/2015 | N/A | -2 | N/A | -3 | N/A |
| 7/31/2015 | N/A | -2 | N/A | -3 | N/A |
| 4/30/2015 | N/A | -2 | N/A | -3 | N/A |
| 1/31/2015 | N/A | -2 | N/A | -2 | N/A |
| 10/31/2014 | N/A | -2 | N/A | -2 | N/A |
| 7/31/2014 | N/A | -2 | N/A | -2 | N/A |
| 4/30/2014 | N/A | -2 | N/A | -2 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: SCP is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: SCP is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: SCP is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: SCP's revenue is expected to decline over the next 3 years (-25% per year).
High Growth Revenue: SCP's revenue is forecast to decline over the next 3 years (-25% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if SCP's Return on Equity is forecast to be high in 3 years time